Literature DB >> 34216688

Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis.

Jie Cai1, Hongda Chen2, Ming Lu2, Yuhan Zhang2, Bin Lu2, Lei You1, Taiping Zhang1, Min Dai3, Yupei Zhao4.   

Abstract

Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiology of pancreatic cancer, including its epidemiological trends, risk factors, risk prediction models, screening modalities, and prognosis. The risk factors for pancreatic cancers can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. Several prediction models for pancreatic cancer have been developed in populations with new-onset diabetes or a family history of pancreatic cancer; however, these models require further validation. Despite recent progress in pancreatic cancer screening, the quantity and quality of related studies are also unsatisfactory, especially with respect to the identification of high-risk populations and development of effective screening modality. Apart from the populations with familial genetic risk and those at a high risk of sporadic pancreatic cancer, risk factors such as new-onset diabetes may be a new direction for timely intervention. We hope this work will provide new ideas for further prevention and treatment of pancreatic cancer.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Pancreatic cancer; Prediction model; Screening; Trend

Mesh:

Year:  2021        PMID: 34216688     DOI: 10.1016/j.canlet.2021.06.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.

Authors:  Wei Xu; Man Zhang; Lu Liu; Minyue Yin; Chunfang Xu; Zhen Weng
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

Review 2.  Understanding Necroptosis in Pancreatic Diseases.

Authors:  Ru He; Zhengfeng Wang; Shi Dong; Zhou Chen; Wence Zhou
Journal:  Biomolecules       Date:  2022-06-13

3.  Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma.

Authors:  Peng Tan; Mo Li; Zhuoran Liu; Tongxi Li; Lingyu Zhao; Wenguang Fu
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

4.  Striatal Isolated from Cyathus striatus Extracts Induces Apoptosis in Human Pancreatic Cancer Cells.

Authors:  Fuad Fares; Soliman Khatib; Jacob Vaya; Lital Sharvit; Einav Eizenberg; Solomon Wasser
Journal:  Molecules       Date:  2022-04-24       Impact factor: 4.927

5.  Hyperthermia Enhances Efficacy of Chemotherapeutic Agents in Pancreatic Cancer Cell Lines.

Authors:  Costanza E Maurici; Robin Colenbier; Britta Wylleman; Luigi Brancato; Eke van Zwol; Johan Van den Bossche; Jean-Pierre Timmermans; Elisa Giovannetti; Marina G M C Mori da Cunha; Johannes Bogers
Journal:  Biomolecules       Date:  2022-04-29

6.  Diagnostic Strategy of Early Stage Pancreatic Cancer via Clinical Predictor Assessment: Clinical Indicators, Risk Factors and Imaging Findings.

Authors:  Ryota Sagami; Takao Sato; Kazuhiro Mizukami; Mitsuteru Motomura; Kazuhisa Okamoto; Satoshi Fukuchi; Yuichiro Otsuka; Takashi Abe; Hideki Ono; Kei Mori; Kurato Wada; Tomoyuki Iwaki; Hidefumi Nishikiori; Koichi Honda; Yuji Amano; Kazunari Murakami
Journal:  Diagnostics (Basel)       Date:  2022-02-01

7.  Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Authors:  Yingkun Xu; Han Li; Ailin Lan; Qiulin Wu; Zhenrong Tang; Dan Shu; Zhaofu Tan; Xin Liu; Yang Liu; Shengchun Liu
Journal:  J Oncol       Date:  2022-09-09       Impact factor: 4.501

8.  Association between Temporal Glycemic Change and Risk of Pancreatic Cancer in Men: A Prospective Cohort Study.

Authors:  Jie Cai; Hongda Chen; Ming Lu; Yuhan Zhang; Bin Lu; Chenyu Luo; Xiaoshuang Feng; Lei You; Min Dai; Yupei Zhao
Journal:  Cancers (Basel)       Date:  2022-07-13       Impact factor: 6.575

Review 9.  Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.

Authors:  Silviu Stanciu; Florentina Ionita-Radu; Constantin Stefani; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Alexandra Ripszky Totan; Mariana Jinga
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.